Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Curvebeam AI Ltd. ( (AU:CVB) ) just unveiled an announcement.
CurveBeam AI Limited announced that all resolutions were passed at its 2025 Annual General Meeting, reflecting strong shareholder support. The successful outcomes of the meeting are expected to positively impact the company’s operations and industry positioning, reinforcing stakeholder confidence in its strategic direction.
The most recent analyst rating on (AU:CVB) stock is a Hold with a A$0.15 price target. To see the full list of analyst forecasts on Curvebeam AI Ltd. stock, see the AU:CVB Stock Forecast page.
More about Curvebeam AI Ltd.
CurveBeam AI Limited is a company that develops, manufactures, and sells specialized medical imaging CT scanners, along with AI SaaS-based clinical assessment solutions. These products support medical practitioners in managing musculoskeletal conditions. The company’s flagship product, HiRise™, offers both weight-bearing and traditional non-weight-bearing CT scans, providing significant advantages over traditional CT or MRI devices. CurveBeam AI operates with over 70 employees, with its corporate office and AI functions based in Melbourne, Australia, and its global operations headquarters in Hatfield, Pennsylvania, USA.
Average Trading Volume: 1,403,283
Technical Sentiment Signal: Sell
Current Market Cap: A$34.62M
Learn more about CVB stock on TipRanks’ Stock Analysis page.